Shingrix in Renal Transplant Recipients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 132 participants.
Also called NCT04128189
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 132 participants
- Registry
-
NCT04128189
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT04128189. Randomized; no masking; primary purpose treatment. Start 2023-03-02 (actual); primary completion 2029-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Shingrix in Renal Transplant Recipients
- Condition
- Kidney Transplant Recipient Response to Shingrix Vaccine
- Condition
- Kidney Failure
- Condition
- Kidney Failure, Chronic
- Condition
- Kidney Transplantation
- Condition
- Herpes Zoster (HZ)
- Intervention (Biological)
- Shingrix
- Lead sponsor
- University of Colorado, Denver
- Collaborator
- GlaxoSmithKline
Record details
- Record id
cardio:ct-nct04128189- Content hash
d03865604ad7552890eeedf4980471dfd868499ca45acb9f76912d3094756b12